Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
A therapeutic approach to Alzheimer's disease aimed at improving brain perfusion and counteracting cerebrovascular and amyloidosis pathologies
EF 2009-10
Résumé
Alzheimer's disease is a debilitating neurological disorder and currently has no cure. It is the most frequent type of dementia and is characterized by mild to severe memory deficits. Currently, there are not many therapeutic options. An anti-hypertensive drug which has proved in the lab to normalize the memory deficits as well as the abnormal blood flow in the brain as seen in Alzheimer's disease, will be tested on the mouse model for the disease, along with different drugs affecting the cholinergic system in the brain. It has been hypothesized that the cholinergic system plays a role in the disease pathology, and it has been a target for potential therapies. This project aims to see if the effects of the cholinergic system really does play a significant role, and if perhaps a more viable target for effective Alzheimer's disease therapy would simply involve the anti-hypertensive drug without modulation by the cholinergic system. If the cholinergic system proves to be ineffective, it will save much time and effort which is currently being put into advancing these drugs as practical clinical therapies, and help steer the research community towards perhaps more effective options.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
200341
Name
Mills Jessica T
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Aging
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
A therapeutic approach to Alzheimer's disease aimed at improving brain perfusion and counteracting cerebrovascular and amyloidosis pathologies
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
192 Igg-Saporin; Alzheimer'S Disease; Amyloid-Beta Peptide; Cerebral Blood Flow; Cholinergic Neurotransmission; Laser Doppler; Learning; Linopirdine; Memory; Physostigmine
Abstract
Alzheimer's disease is a debilitating neurological disorder and currently has no cure. It is the most frequent type of dementia and is characterized by mild to severe memory deficits. Currently, there are not many therapeutic options. An anti-hypertensive drug which has proved in the lab to normalize the memory deficits as well as the abnormal blood flow in the brain as seen in Alzheimer's disease, will be tested on the mouse model for the disease, along with different drugs affecting the cholinergic system in the brain. It has been hypothesized that the cholinergic system plays a role in the disease pathology, and it has been a target for potential therapies. This project aims to see if the effects of the cholinergic system really does play a significant role, and if perhaps a more viable target for effective Alzheimer's disease therapy would simply involve the anti-hypertensive drug without modulation by the cholinergic system. If the cholinergic system proves to be ineffective, it will save much time and effort which is currently being put into advancing these drugs as practical clinical therapies, and help steer the research community towards perhaps more effective options.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mills, Jessica T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~